Where our team of guest writers discuss what they think about the current NGP US Issues.
Sean Harper tells NGP why he is excited about potential new treatments for osteoporosis, why animal models aren't always useful in developing...
Moncef Slaoui has a tough job ahead of him - restructuring GlaxoSmithKline's R&D organization in order to ensure the company's future. But...
Certain tactics in pharmaceutical marketing have tarnished the industry's reputation in recent times. Todd Evans of PwC looks at the new...

As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.